Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
by
McCaig, Alison M.
, Cosimo, Emilio
, Leach, Michael T.
, Michie, Alison M.
in
Actin
/ Actins - chemistry
/ Adult
/ Aged
/ AKT protein
/ Animals
/ Antigens
/ Apoptosis
/ B-cell receptor
/ Biology
/ Cancer
/ Cell adhesion & migration
/ Cell Movement
/ Chemokine CXCL12 - metabolism
/ Chemokines
/ Chemoresistance
/ Chemotaxis
/ Chronic lymphocytic leukemia
/ CXCL12 protein
/ CXCR4 protein
/ Dasatinib
/ Enzyme inhibitors
/ Extracellular signal-regulated kinase
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Female
/ Flow cytometry
/ Gene Expression Regulation, Leukemic
/ Health aspects
/ Hematology
/ Humans
/ Laboratories
/ Leukemia
/ Leukocyte migration
/ Life sciences
/ Ligands
/ Lymphocytes B
/ Male
/ Medicine
/ Mice
/ Middle Aged
/ Muscle proteins
/ Peripheral blood
/ Phosphorylation
/ Protein Kinase Inhibitors - pharmacology
/ Protein-tyrosine kinase
/ Pyrimidines - pharmacology
/ Receptors, CXCR4 - metabolism
/ Signal Transduction
/ Signaling
/ Spleen
/ Stimulation
/ T cell receptors
/ Thiazoles - pharmacology
/ Tissues
/ Tumors
/ Tyrosine
2012
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
by
McCaig, Alison M.
, Cosimo, Emilio
, Leach, Michael T.
, Michie, Alison M.
in
Actin
/ Actins - chemistry
/ Adult
/ Aged
/ AKT protein
/ Animals
/ Antigens
/ Apoptosis
/ B-cell receptor
/ Biology
/ Cancer
/ Cell adhesion & migration
/ Cell Movement
/ Chemokine CXCL12 - metabolism
/ Chemokines
/ Chemoresistance
/ Chemotaxis
/ Chronic lymphocytic leukemia
/ CXCL12 protein
/ CXCR4 protein
/ Dasatinib
/ Enzyme inhibitors
/ Extracellular signal-regulated kinase
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Female
/ Flow cytometry
/ Gene Expression Regulation, Leukemic
/ Health aspects
/ Hematology
/ Humans
/ Laboratories
/ Leukemia
/ Leukocyte migration
/ Life sciences
/ Ligands
/ Lymphocytes B
/ Male
/ Medicine
/ Mice
/ Middle Aged
/ Muscle proteins
/ Peripheral blood
/ Phosphorylation
/ Protein Kinase Inhibitors - pharmacology
/ Protein-tyrosine kinase
/ Pyrimidines - pharmacology
/ Receptors, CXCR4 - metabolism
/ Signal Transduction
/ Signaling
/ Spleen
/ Stimulation
/ T cell receptors
/ Thiazoles - pharmacology
/ Tissues
/ Tumors
/ Tyrosine
2012
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
by
McCaig, Alison M.
, Cosimo, Emilio
, Leach, Michael T.
, Michie, Alison M.
in
Actin
/ Actins - chemistry
/ Adult
/ Aged
/ AKT protein
/ Animals
/ Antigens
/ Apoptosis
/ B-cell receptor
/ Biology
/ Cancer
/ Cell adhesion & migration
/ Cell Movement
/ Chemokine CXCL12 - metabolism
/ Chemokines
/ Chemoresistance
/ Chemotaxis
/ Chronic lymphocytic leukemia
/ CXCL12 protein
/ CXCR4 protein
/ Dasatinib
/ Enzyme inhibitors
/ Extracellular signal-regulated kinase
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Female
/ Flow cytometry
/ Gene Expression Regulation, Leukemic
/ Health aspects
/ Hematology
/ Humans
/ Laboratories
/ Leukemia
/ Leukocyte migration
/ Life sciences
/ Ligands
/ Lymphocytes B
/ Male
/ Medicine
/ Mice
/ Middle Aged
/ Muscle proteins
/ Peripheral blood
/ Phosphorylation
/ Protein Kinase Inhibitors - pharmacology
/ Protein-tyrosine kinase
/ Pyrimidines - pharmacology
/ Receptors, CXCR4 - metabolism
/ Signal Transduction
/ Signaling
/ Spleen
/ Stimulation
/ T cell receptors
/ Thiazoles - pharmacology
/ Tissues
/ Tumors
/ Tyrosine
2012
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
Journal Article
Dasatinib Inhibits CXCR4 Signaling in Chronic Lymphocytic Leukaemia Cells and Impairs Migration Towards CXCL12
2012
Request Book From Autostore
and Choose the Collection Method
Overview
Chemokines and their ligands play a critical role in enabling chronic lymphocytic leukaemia (CLL) cells access to protective microenvironmental niches within tissues, ultimately resulting in chemoresistance and relapse: disruption of these signaling pathways has become a novel therapeutic approach in CLL. The tyrosine kinase inhibitor dasatinib inhibits migration of several cell lines from solid-organ tumours, but effects on CLL cells have not been reported. We studied the effect of clinically achievable concentrations of dasatinib on signaling induced by the chemokine CXCL12 through its' receptor CXCR4, which is highly expressed on CLL cells. Dasatinib pre-treatment inhibited Akt and ERK phosphorylation in CLL cells upon stimulation with CXCL12. Dasatinib also significantly diminished the rapid increase in actin polymerisation observed in CLL cells following CXCL12 stimulation. Moreover, the drug significantly inhibited chemotaxis in a transwell assay, and reduced the percentage of cells able to migrate beneath a CXCL12-expressing murine stromal cell line. Dasatinib also abrogated the anti-apoptotic effect of prolonged CXCL12 stimulation on cultured CLL cells. These data suggest that dasatinib, akin to other small molecule kinase inhibitors targeting the B-cell receptor signaling pathway, may redistribute CLL cells from protective tissue niches to the peripheral blood, and support the investigation of dasatinib in combination strategies.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Adult
/ Aged
/ Animals
/ Antigens
/ Biology
/ Cancer
/ Chemokine CXCL12 - metabolism
/ Chronic lymphocytic leukemia
/ Extracellular signal-regulated kinase
/ Extracellular Signal-Regulated MAP Kinases - metabolism
/ Female
/ Gene Expression Regulation, Leukemic
/ Humans
/ Leukemia
/ Ligands
/ Male
/ Medicine
/ Mice
/ Protein Kinase Inhibitors - pharmacology
/ Receptors, CXCR4 - metabolism
/ Spleen
/ Tissues
/ Tumors
/ Tyrosine
This website uses cookies to ensure you get the best experience on our website.